MELISSA DOVE: Open Payments
NPI 1902854128 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 63 payments from 27 companies in 2025. Trend: 2023 $6,231 · 2024 $1,325 · 2025 $1,448
Food & beverage: $1,283Education: $165
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $222 |
| Daiichi Sankyo Inc. | 5 | $177 |
| PFIZER INC. | 6 | $124 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| Genentech USA, Inc. | 3 | $70 |
| GENZYME CORPORATION | 3 | $64 |
| Astellas Pharma US Inc | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Lilly USA, LLC | 3 | $47 |
Products named: Enhertu, RYBREVANT, KEYTRUDA, LUTATHERA, ELREXFIO, Padcev, VERZENIO, TECVAYLI.
Industry payments across OH — which companies pay providers there.
